Research Directory

How genome editing is impacting cell therapy

Read more

Acesion Pharma's new approach to atrial fibrillation

Read more

European biotechs mixed in quarter

Read more

What Roche's takeover of Flatiron Health really means

Read more

Innate Pharma aims to regain leadership in IO

Read more

Antibody-degrading enzyme enables transplants

Read more

Mitochondrial quality control as potential therapy

Read more

Building a European capital market

Read more

The new complexity in clinical study protocols

Read more

Cell therapy success and the competition for value

Read more